Cornelis K. van der Ent

16.6k total citations · 5 hit papers
310 papers, 9.9k citations indexed

About

Cornelis K. van der Ent is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Cornelis K. van der Ent has authored 310 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 216 papers in Pulmonary and Respiratory Medicine, 67 papers in Physiology and 52 papers in Epidemiology. Recurrent topics in Cornelis K. van der Ent's work include Cystic Fibrosis Research Advances (137 papers), Neonatal Respiratory Health Research (78 papers) and Asthma and respiratory diseases (62 papers). Cornelis K. van der Ent is often cited by papers focused on Cystic Fibrosis Research Advances (137 papers), Neonatal Respiratory Health Research (78 papers) and Asthma and respiratory diseases (62 papers). Cornelis K. van der Ent collaborates with scholars based in Netherlands, United States and United Kingdom. Cornelis K. van der Ent's co-authors include Jeffrey M. Beekman, Johanna F. Dekkers, Cuno S.P.M. Uiterwaal, Jan L. L. Kimpen, Tom F.W. Wolfs, Hubertus G.M. Arets, Hans Clevers, Edward E. S. Nieuwenhuis, Karin M. de Winter‐de Groot and Hettie M. Janssens and has published in prestigious journals such as New England Journal of Medicine, JAMA and Nature Medicine.

In The Last Decade

Cornelis K. van der Ent

302 papers receiving 9.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Functional Repair of CFTR by CRISPR/Cas9 in Intestinal Stem Cell Organoids of Cystic Fibrosis Patients

2013 1.0k citations Johanna F. Dekkers, Cornelis K. van der Ent et al. profile →
A functional CFTR assay using primary cystic fibrosis intestinal organoids

2013 734 citations Johanna F. Dekkers, Inez Bronsveld et al. profile →
Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del

2017 553 citations Jennifer L. Taylor‐Cousar, À. Munck et al. New England Journal of Medicine profile →
Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis

2016 401 citations Johanna F. Dekkers, Gitte Berkers et al. profile →
Healthy play, better coping: The importance of play for the development of children in health and disease

2018 186 citations Sanne L. Nijhof, E. J. Marijke Achterberg et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cornelis K. van der Ent Netherlands	46	5.3k	2.0k	1.7k	1.5k	810	310	9.9k
Scott C. Bell Australia	54	6.2k 1.2×	2.1k 1.0×	708 0.4×	2.0k 1.3×	517 0.6×	290	10.9k
Robert Bals Germany	58	3.2k 0.6×	4.1k 2.0×	1.7k 1.0×	1.5k 1.0×	640 0.8×	378	14.2k
Isabelle Sermet‐Gaudelus France	49	6.8k 1.3×	1.6k 0.8×	897 0.5×	1.9k 1.2×	652 0.8×	259	10.1k
Bruce C. Marshall United States	52	10.0k 1.9×	1.5k 0.7×	943 0.6×	2.5k 1.7×	1.3k 1.6×	138	13.2k
Félix Ratjen Canada	65	14.9k 2.8×	2.5k 1.2×	2.8k 1.6×	2.2k 1.5×	1.3k 1.6×	452	18.1k
James R. Yankaskas United States	53	6.7k 1.3×	3.5k 1.7×	965 0.6×	1.1k 0.7×	1.1k 1.4×	103	10.8k
Frank J. Accurso United States	57	9.9k 1.9×	2.0k 1.0×	1.3k 0.8×	1.8k 1.2×	1.0k 1.2×	191	12.5k
Joseph M. Pilewski United States	63	5.7k 1.1×	2.9k 1.4×	1.7k 1.0×	2.5k 1.6×	3.1k 3.8×	309	13.5k
K. De Boeck Belgium	49	7.0k 1.3×	1.4k 0.7×	1.2k 0.7×	1.0k 0.7×	755 0.9×	250	8.9k
Noel G. McElvaney Ireland	74	8.7k 1.6×	4.6k 2.3×	1.9k 1.1×	1.8k 1.2×	872 1.1×	360	17.8k

Countries citing papers authored by Cornelis K. van der Ent

Since Specialization

Citations

This map shows the geographic impact of Cornelis K. van der Ent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cornelis K. van der Ent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cornelis K. van der Ent more than expected).

Fields of papers citing papers by Cornelis K. van der Ent

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cornelis K. van der Ent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cornelis K. van der Ent. The network helps show where Cornelis K. van der Ent may publish in the future.

Co-authorship network of co-authors of Cornelis K. van der Ent

This figure shows the co-authorship network connecting the top 25 collaborators of Cornelis K. van der Ent. A scholar is included among the top collaborators of Cornelis K. van der Ent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cornelis K. van der Ent. Cornelis K. van der Ent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Michel, Sabine, et al.. (2024). WS10.05 Subject selection plan for CHOICES clinical trial aiming to assess efficacy of newCFTR modulators and to validate the intestinal organoid model. Journal of Cystic Fibrosis. 23. S19–S19. 1 indexed citations

Achterberg, E. J. Marijke, et al.. (2024). Effect of social play deprivation on stress sensitivity in response to social and non-social challenges. SHILAP Revista de lepidopterología. 3.

Veldhoen, Esther S., Roelie M. Wösten‐van Asperen, Michael A. Gaytant, et al.. (2023). Evidence for Beneficial Effect of Daily Use of Mechanical Insufflation-Exsufflation in Patients With Neuromuscular Diseases. Respiratory Care. 68(4). 531–546. 5 indexed citations

Hoesein, Firdaus A. A. Mohamed, et al.. (2023). Radiological and long‐term clinical response to elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with advanced lung disease. Pediatric Pulmonology. 58(8). 2317–2322. 6 indexed citations

Spelier, Sacha, et al.. (2023). Readthrough compounds for nonsense mutations: bridging the translational gap. Trends in Molecular Medicine. 29(4). 297–314. 38 indexed citations

Janssens, Hettie M., et al.. (2023). CFTR Function Restoration upon Elexacaftor/Tezacaftor/Ivacaftor Treatment in Patient-Derived Intestinal Organoids with Rare CFTR Genotypes. International Journal of Molecular Sciences. 24(19). 14539–14539. 22 indexed citations

Takken, Tim, et al.. (2022). Physiological predictors of cardiorespiratory fitness in children and adolescents with cystic fibrosis without ventilatory limitation. Therapeutic Advances in Respiratory Disease. 16. 2663649471–2663649471.

Berkers, Gitte, Renske van der Meer, Annelotte M. Vonk, et al.. (2019). Forskolin-induced swelling of intestinal organoids correlates with disease severity in adults with cystic fibrosis and homozygous F508del mutations. Journal of Cystic Fibrosis. 19(4). 614–619. 38 indexed citations

Taylor‐Cousar, Jennifer L., À. Munck, Edward F. McKone, et al.. (2017). Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del. New England Journal of Medicine. 377(21). 2013–2023. 553 indexed citations breakdown →

10.

Berkers, Gitte, et al.. (2016). The effect of treatment with ivacaftor on the respiratory microbial composition in the upper and lower airways. Pediatric Pulmonology. 51. 306–306. 1 indexed citations

11.

Prevaes, Sabine M. P. J., Karin M. de Winter‐de Groot, Hettie M. Janssens, et al.. (2015). Development of the Nasopharyngeal Microbiota in Infants with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 193(5). 504–515. 101 indexed citations

12.

Terheggen-Lagro, Suzanne W. J., et al.. (2013). Apical CFTR Expression in Human Nasal Epithelium Correlates with Lung Disease in Cystic Fibrosis. PLoS ONE. 8(3). e57617–e57617. 15 indexed citations

13.

Rooijakkers, Suzan H. M., et al.. (2013). Optimal Complement-Mediated Phagocytosis of Pseudomonas aeruginosa by Monocytes Is Cystic Fibrosis Transmembrane Conductance Regulator–Dependent. American Journal of Respiratory Cell and Molecular Biology. 49(3). 463–470. 58 indexed citations

14.

Putte‐Katier, Nienke van, Anne C. van der Gugten, Cuno S.P.M. Uiterwaal, et al.. (2012). Early life lung function and respiratory outcome in the first year of life. European Respiratory Journal. 40(1). 198–205. 6 indexed citations

15.

Zalm, Marieke M. van der, et al.. (2010). The Influence of Neonatal Lung Function on Rhinovirus-associated Wheeze. American Journal of Respiratory and Critical Care Medicine. 183(2). 262–267. 37 indexed citations

16.

Arets, Hubertus G.M., et al.. (2009). Comparing 6 and 10 sec exhalation time in exhaled nitric oxide measurements in children. Pediatric Pulmonology. 44(4). 340–344. 11 indexed citations

17.

Terheggen‐Lagro, Suzanne, et al.. (2009). Analysis of CFTR expression in immune cell subsets of peripheral blood. Journal of Cystic Fibrosis. 8. S56–S56. 1 indexed citations

18.

Lindemans, Caroline A., Jan L. L. Kimpen, Bart Luijk, et al.. (2006). Systemic eosinophil response induced by respiratory syncytial virus. Clinical & Experimental Immunology. 144(3). 409–417. 32 indexed citations

19.

Ewijk, Bart E. van, Marieke M. van der Zalm, Tom F.W. Wolfs, & Cornelis K. van der Ent. (2005). Viral respiratory infections in cystic fibrosis. Journal of Cystic Fibrosis. 4. 31–36. 67 indexed citations

20.

Gracchi, Valentina, Machteld E. Boel, J. van der Laag, & Cornelis K. van der Ent. (2003). Spirometry in young children: should computer-animation programs be used during testing?. European Respiratory Journal. 21(5). 872–875. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact